Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05243563 · ClinicalTrials.gov registry record · Phase 2
Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?
A Phase 2 study, sponsored by University of South Alabama.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT05243563: Clinical Trial Phase 2 study, sponsored by University of South Alabama.
NCT05243563 is a Phase 2 study that was terminated before completion, run by University of South Alabama. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05243563, a Phase 2 study, was terminated before completion, sponsored by University of South Alabama.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will compare the effects of fractionated CO2 laser plus topical steroids versus topical steroids alone in treatment of lichen sclerosus.
Interventions
- DRUG Topical steroid
- DEVICE MonaLisa Touch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2022-04-13 |
| Est. Completion | 2024-06-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05243563
The ClinicalTrials.gov registry entry for NCT05243563 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical steroid is the first listed.
NCT05243563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05243563 about?
NCT05243563 is a clinical study titled "Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?". This study will compare the effects of fractionated CO2 laser plus topical steroids versus topical steroids alone in treatment of lichen sclerosus.
What is the current status of trial NCT05243563?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2022-04-13. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT05243563?
The interventions under investigation include: Topical steroid (DRUG), MonaLisa Touch (DEVICE).
Who is sponsoring clinical trial NCT05243563?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.